DK0871457T3 - Isolerede stromaceller og fremgangsmåder til anvendelse heraf - Google Patents
Isolerede stromaceller og fremgangsmåder til anvendelse herafInfo
- Publication number
- DK0871457T3 DK0871457T3 DK96912514T DK96912514T DK0871457T3 DK 0871457 T3 DK0871457 T3 DK 0871457T3 DK 96912514 T DK96912514 T DK 96912514T DK 96912514 T DK96912514 T DK 96912514T DK 0871457 T3 DK0871457 T3 DK 0871457T3
- Authority
- DK
- Denmark
- Prior art keywords
- stromal cells
- methods
- isolated stromal
- isolated
- bone
- Prior art date
Links
- 210000002536 stromal cell Anatomy 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1311—Osteocytes, osteoblasts, odontoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/02—Cells from transgenic animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/412,066 US5716616A (en) | 1995-03-28 | 1995-03-28 | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
US662795P | 1995-11-13 | 1995-11-13 | |
PCT/US1996/004407 WO1996030031A1 (en) | 1995-03-28 | 1996-03-28 | Isolated stromal cells and methods of using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0871457T3 true DK0871457T3 (da) | 2003-07-28 |
Family
ID=26675866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96912514T DK0871457T3 (da) | 1995-03-28 | 1996-03-28 | Isolerede stromaceller og fremgangsmåder til anvendelse heraf |
Country Status (9)
Country | Link |
---|---|
EP (3) | EP1304113B1 (da) |
JP (1) | JPH11509171A (da) |
AT (3) | ATE367819T1 (da) |
CA (1) | CA2215143A1 (da) |
DE (3) | DE69637185T2 (da) |
DK (1) | DK0871457T3 (da) |
ES (3) | ES2200061T3 (da) |
HK (2) | HK1055255A1 (da) |
WO (1) | WO1996030031A1 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US6653134B2 (en) * | 1995-03-28 | 2003-11-25 | Cp Hahnemann University | Isolated stromal cells for use in the treatment of diseases of the central nervous system |
EP2179738A3 (en) * | 1997-01-24 | 2010-05-05 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating osteoporosis |
US7514074B2 (en) | 1997-07-14 | 2009-04-07 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
CA2348770A1 (en) * | 1998-10-26 | 2000-05-04 | Philadelphia Health & Education Corporation | Stromal cell use |
UA64826C2 (uk) * | 1998-12-16 | 2004-03-15 | Центр Ембріональних Тканин "Емселл" | Спосіб лікування людей ембріональними клітинними суспензіями |
US6713293B1 (en) * | 1999-02-08 | 2004-03-30 | Friedrich Grummt | Encapsulated cells containing an amplified expression vector as a drug delivery device |
DE60129943T2 (de) | 2000-02-11 | 2008-05-08 | Philadelphia Health And Education Corp. | Differenzierung von knochenmarkzellen in neuronale zellen und deren verwendungen |
US20030003090A1 (en) | 2001-05-31 | 2003-01-02 | Prockop Darwin J. | Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
US7485460B2 (en) | 2003-05-21 | 2009-02-03 | Tulane University Health Sciences Center | Enhanced growth of adult stem cells with Dkk-1 |
EP2824174B1 (en) | 2004-03-22 | 2018-11-28 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
EP2630959A1 (en) | 2007-02-12 | 2013-08-28 | Anthrogenesis Corporation | Treatment of inflammatory diseases using placental stem cells |
US9506035B2 (en) * | 2009-10-13 | 2016-11-29 | University Of Louisville Research Foundation, Inc | Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells |
WO2012156968A2 (en) | 2011-05-19 | 2012-11-22 | Ariel - University Research And Development Company, Ltd. | Use of mesenchymal stem cells for the improvement of affective and cognitive function |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4904259A (en) * | 1988-04-29 | 1990-02-27 | Samuel Itay | Compositions and methods for repair of cartilage and bone |
EP0381490B1 (en) * | 1989-02-02 | 1994-09-21 | Joel S. Greenberger | Gene therapy using stromal cells |
US5334640A (en) * | 1992-04-08 | 1994-08-02 | Clover Consolidated, Ltd. | Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods |
US5631236A (en) * | 1993-08-26 | 1997-05-20 | Baylor College Of Medicine | Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
-
1996
- 1996-03-28 CA CA002215143A patent/CA2215143A1/en not_active Abandoned
- 1996-03-28 AT AT03075116T patent/ATE367819T1/de not_active IP Right Cessation
- 1996-03-28 WO PCT/US1996/004407 patent/WO1996030031A1/en active IP Right Grant
- 1996-03-28 DE DE69637185T patent/DE69637185T2/de not_active Expired - Lifetime
- 1996-03-28 EP EP03075116A patent/EP1304113B1/en not_active Expired - Lifetime
- 1996-03-28 DE DE69628452T patent/DE69628452T2/de not_active Expired - Lifetime
- 1996-03-28 AT AT03075115T patent/ATE329603T1/de not_active IP Right Cessation
- 1996-03-28 ES ES96912514T patent/ES2200061T3/es not_active Expired - Lifetime
- 1996-03-28 AT AT96912514T patent/ATE241369T1/de not_active IP Right Cessation
- 1996-03-28 EP EP03075115A patent/EP1304112B1/en not_active Expired - Lifetime
- 1996-03-28 DE DE69636260T patent/DE69636260T2/de not_active Expired - Lifetime
- 1996-03-28 ES ES03075115T patent/ES2266715T3/es not_active Expired - Lifetime
- 1996-03-28 JP JP8529717A patent/JPH11509171A/ja active Pending
- 1996-03-28 DK DK96912514T patent/DK0871457T3/da active
- 1996-03-28 EP EP96912514A patent/EP0871457B1/en not_active Expired - Lifetime
- 1996-03-28 ES ES03075116T patent/ES2291588T3/es not_active Expired - Lifetime
-
2003
- 2003-10-21 HK HK03107615A patent/HK1055255A1/xx not_active IP Right Cessation
- 2003-10-22 HK HK03107643A patent/HK1055390A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0871457B1 (en) | 2003-05-28 |
WO1996030031A1 (en) | 1996-10-03 |
DE69628452D1 (de) | 2003-07-03 |
EP1304112A1 (en) | 2003-04-23 |
HK1055390A1 (en) | 2004-01-09 |
ES2291588T3 (es) | 2008-03-01 |
DE69637185T2 (de) | 2008-04-10 |
EP1304113A1 (en) | 2003-04-23 |
CA2215143A1 (en) | 1996-10-03 |
ATE367819T1 (de) | 2007-08-15 |
ES2266715T3 (es) | 2007-03-01 |
EP1304113B1 (en) | 2007-07-25 |
ATE329603T1 (de) | 2006-07-15 |
HK1055255A1 (en) | 2004-01-02 |
DE69637185D1 (de) | 2007-09-06 |
ES2200061T3 (es) | 2004-03-01 |
EP1304112B1 (en) | 2006-06-14 |
EP0871457A1 (en) | 1998-10-21 |
EP0871457A4 (en) | 2000-08-23 |
DE69636260T2 (de) | 2007-07-05 |
DE69628452T2 (de) | 2004-03-11 |
ATE241369T1 (de) | 2003-06-15 |
JPH11509171A (ja) | 1999-08-17 |
DE69636260D1 (de) | 2006-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0871457T3 (da) | Isolerede stromaceller og fremgangsmåder til anvendelse heraf | |
ATE171472T1 (de) | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 | |
DE69739105D1 (de) | Survivin, ein protein das zelluläre apoptosis hemmt, und dessen modulation | |
DE69607476D1 (de) | System zur blutanalyse, mit mitteln zur aufbewahrung und zum transport des blutes, sowie zur selbsttätigen herstellung von blutauftragsproben | |
NO873753L (no) | Periodisk biologisk luftbehandlingsprosess og system for denne. | |
DE69510810D1 (de) | Lamanin-ketten: diagnostische und therapeutische verwendung | |
MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
NO20011283D0 (no) | Anvendelse av integrin-antagonister ved behandling av multippelt myelom og myelom-indusert benresorpsjon | |
WO2000012703A3 (en) | Protein transport-associated molecules | |
AU1855401A (en) | Screening method for candidate drugs | |
DE69504959D1 (de) | Humanisierte monoklonale antikörper gegen humanes interleukin - 4 | |
EP1254260A4 (en) | METHODS FOR DIAGNOSING AND TREATING A HEART DISEASE | |
DK0914043T3 (da) | Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf | |
DE60035697D1 (de) | Screening nach verbindungen, die tgf-beta abhängige zellsignale modifizieren können | |
DE50213290D1 (de) | Erfassung von signalen biologischen ursprungs | |
ATE288498T1 (de) | Methoden zur inhibierung von helicobacter pylori | |
DE69612628D1 (de) | Implantierbare, medizinische vorrichtung zur analyse von herzrythmusabweichungen | |
AU4654097A (en) | Rdgb-proteins | |
DE3860200D1 (de) | Verfahren und mittel zur bekaempfung der kaffeeminiermotte, insbesondere der art perileucoptera coffeella. | |
WO2000000510A1 (en) | MODULATORS OF THE GROWTH FACTOR | |
UA31515A (uk) | Спосіб усунення тотального дефекту нижньої губи | |
CY1116745T1 (el) | Vegf για χρηση στη θεραπευτικη αγωγη διαταραχων κεντρικου νευρικου συστηματος | |
IT1270614B (it) | Proteine ad attivita' antitumorale da organi di mammiferi | |
ATE124722T1 (de) | Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung. | |
SE9604502D0 (sv) | Förfarande för blodmikrospektralanalys |